Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Off Script: A Pharma Manufacturing Podcast

Off Script: A Pharma Manufacturing Podcast artwork

How Manufacturers Manage Pipelines in an Uncertain Market

Oct 27, 202630 minAudioEpisode 150
ShareXLinkedInFacebookWhatsAppEmail

Despite ongoing geopolitical and regulatory pressures, life sciences manufacturers continue to invest in their product pipelines while also being more deliberate about long-term portfolio decisions. As interest in peptides, ADCs, and cell and gene therapies continues, manufacturers are weighing the complexity and costs of developing these medicines against the need to scale production and improve patient access. Decisions about outsourcing and building in-house capabilities are also shaping investment strategies. This episode of Off Script closes out our series exploring findings from CRB’s Horizons: Life Sciences 2026 report, focusing on the section addressing pipeline expansion in a pressure-tested market. We spoke with Mark Hsu and Maddie Kelly, process engineers at CRB and co-authors of the section, to discuss what's driving investment in emerging modalities, the challenges of scaling complex therapies and making them more affordable, and how manufacturers are weighing CDMO partnerships against developing their own capabilities.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Preparing the Pharma Workforce for Manufacturing Growth

    Nov 17, 202619 minAudio

    Ongoing investments to expand pharmaceutical manufacturing in the U.S. are creating demand for skilled workers, making it increasingly important to strengthen the talent pool to meet industry need. At the same time,...

    Credit the people on this episode

  2. How Engineered Yeast Could Reduce Biomanufacturing Costs

    Nov 10, 202624 minAudio

    In biomanufacturing, recovering intracellular bioproducts after fermentation can be a costly and energy-intensive process. To address this challenge, researchers are developing new approaches to reduce energy...

    Credit the people on this episode

  3. Adapting Drug Development in a Tighter Funding Environment

    Nov 3, 202616 minAudio

    Tighter funding conditions are putting greater pressure on emerging biotech to reach key development milestones quickly while managing limited budgets. That environment is also changing what sponsors expect from their...

    Credit the people on this episode

  4. Solutions Spotlight: Applying Flow Chemistry to Complex Pharmaceutical Manufacturing

    Oct 23, 202625 minAudio

    Pharmaceutical manufacturers working with hazardous and difficult-to-control chemical reactions face challenges in managing process safety, heat transfer, and reaction conditions. Flow chemistry offers an alternative to...

    Credit the people on this episode

  5. The Changing Economics of Pharma Manufacturing

    Oct 20, 202620 minAudio

    Increased regulatory scrutiny, onshoring efforts, and supply chain vulnerabilities are reshaping how life sciences manufacturers are making investment decisions across the industry. Pharma manufacturers are weighing...

    Credit the people on this episode